Article date: November 1986
By: DO Rumiantsev, VK Piotrovskii, OS Riabokon, ID Slastnikova, EV Kokurina, VI Metelitsa, in Volume 22, Issue 5, pages 606-609
The influence of chronic verapamil treatment on antipyrine elimination was studied in eight angina patients. Antipyrine half‐life (mean +/‐ s.d.) was 13.1 +/‐ 1.15 h at the start of therapy and 16.6 +/‐ 3.05 h (P less than 0.05) during chronic oral administration of verapamil (80‐ 120 mg four or three times daily for 4 to 7 months). There was a significant decrease in antipyrine clearance (mean +/‐ s.d, 43.2 +/‐ 16.8 ml min‐1 vs 28.7 +/‐ 16.6 ml min‐1, P less than 0.01) while the change of distribution volume was insignificant. Verapamil elimination was also found to be impaired after chronic dosing as compared to single administration. Half‐lives measured from the concentration vs time and urinary excretion rate vs time curves were both prolonged and oral clearance was decreased. Our results suggest that the inhibition of drug‐metabolizing enzymes accounts for the impairment of verapamil elimination on chronic administration.
DOI: 10.1111/j.1365-2125.1986.tb02942.x
View this article